ClinicalTrials.Veeva

Menu

Exercise Preconditioning in Ovarian Cancer

University of Virginia logo

University of Virginia

Status

Terminated

Conditions

Ovarian Cancer

Treatments

Behavioral: Attention control
Behavioral: High intensity interval exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT05029154
HSR210169

Details and patient eligibility

About

The purpose of this study is to determine if exercise preconditioning can mitigate the off target effects of chemotherapy treatment on measures of cardiovascular function, peripheral neuropathy, and quality of life.

Full description

While survivorship for those diagnosed with epithelial ovarian cancer has continued to improve, the significant off target effects of adjuvant and neoadjuvant chemotherapy have become more prominent. These off-target effects include increased risk of cardiovascular disease, neuropathy, and decreased quality of life. Exercise initiated prior to chemotherapy induction and continued through treatment has promise in terms of preserving VO2peak and potentially mitigating the negative cardiovascular and neuropathic effects of chemotherapy. The goal of this study is to examine the effects of initiating exercise prior to any oncologic therapy and sustaining this exercise paradigm in newly diagnosed women with ovarian cancer who are undergoing initial surgery and chemotherapy.

Enrollment

8 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age 18 years or over
  • Presumed diagnosis of ovarian cancer and a planned chemotherapy regimen of a taxane and carboplatin with or without VEGF inhibition
  • Physician clearance for exercise training

Exclusion criteria

  • Any patient unable/unwilling to cooperate with all study protocols
  • Cancer recurrence
  • Previous treatment with chemotherapy in the last 5-years
  • Medical/orthopedic co-morbidities that preclude exercise training
  • Significant heart, liver, kidney, blood, or respiratory disease precluding exercise participation
  • Peripheral vascular disease
  • Acute infectious disease or history of chronic infections

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

8 participants in 2 patient groups, including a placebo group

Exercise
Experimental group
Description:
Patients in the exercise group will perform interval training 3 days per week.
Treatment:
Behavioral: High intensity interval exercise
Attention Control
Placebo Comparator group
Description:
Physical activity education and physical activity monitoring.
Treatment:
Behavioral: Attention control

Trial contacts and locations

1

Loading...

Central trial contact

Susan Modesitt, MD; Siddhartha S Angadi, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems